Testing for ESR1 Mutations Recommended in HR+, HER2- Metastatic Breast Cancer
Routine testing for ESR1 mutations should occur upon recurrence or progression of HR+, HER2- metastatic breast cancer, a guideline suggests.
Diagnosis & Disease Information
Better Counseling, Uptake of BRCA1/2 Testing Needed in Hereditary Breast and Ovarian Cancer
A review of the literature identified interventions that may increase understanding and uptake of genetic testing for BRCA1/2 variants.
NGS Reveals Actionable Mutations, Leads to Diagnosis in Cancer of Unknown Primary
NGS can reveal targetable mutations and aid diagnosis for patients with cancer of unknown primary, a study suggests.
Initiative Increased BRCA Testing in Ovarian Cancer Patients
A multipronged initiative increased germline BRCA mutation testing for patients with ovarian cancer by 31%.
Clinical Risk Score in HR+/ERBB2- Breast Cancer an Indicator for Routine Genetic Testing
Researchers compared methods for recurrence risk assessment to determine the clinical utility of genetic risk assessment compared with clinical risk assessment.
Biomarker Test Reports Should Be More Patient- and Provider-Friendly
Researchers sought to identify the challenges that patients and healthcare providers experience with understanding and using biomarker test results.
Engaging Patients to Improve Genetic Risk Assessment and Testing
Preliminary results of a study comparing outreach methods for engaging patients in genetic risk assessment and testing are presented.
Factors Associated With Increased Distress and Uncertainty in Individuals Undergoing Multigene Genetic Testing
Survey study measured factors that affect levels of distress and uncertainty in a diverse population of patients undergoing multigene hereditary cancer testing.
Expert Panel Provides Guidance on Prostate Cancer Genetic Testing
A panel of experts agreed that men with metastatic prostate cancer may be the most appropriate candidates for comprehensive genetic testing.
Genetic Testing Recommended for All Men With Metastatic Prostate Cancer
New recommendations from an international consensus conference call for genetic testing of all men with metastatic prostate cancer (PCa) and those with a family history indicative of hereditary PCa and suggest strategies for genetic evaluation.
- Loading...
Loading...
Next post in Prostate Cancer
Loading... 
Loading...